The following temporary anatomical therapeutic chemical (ATC) classifications, defined daily doses (DDDs) and alterations were agreed at a meeting of the WHO International Working Group for Drug Statistics Methodology which took place on 23-24 October 2002. Comments or objections to the decisions from the meeting should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology, e-mail: whocc@nmd.no.before 1 February 2003. If no objections are received before this date, the new ATC codes and DDDs will be considered final and be included in the January 2004 issue of the ATC index. The inclusion of a substance in the lists does not imply any recommendation of use in medicine or pharmacy.

ATC level

INN/Common name

ATC code

New ATC level codes (other than 5^th levels):

Direct thrombin inhibitors

B01AE

Other anterior pituitary hormones and analogues

H01AX

Prostaglandin analogues

S01EE

New ATC 5th level codes:

adalimumab

L04AA17

adefovir dipivoxil

J05AF08

afelimomab

L04AA16

alefacept

L04AA15

aluminium diacetate

D10AX05

argatroban

B01AE03

benidipine

C08CA15

beraprost

B01AC19

bimatoprost

S01EE03

carbon dioxide

V03AN02

ciclesonide

R03BA08

combinations

D06AX30

docosanol

D06BB11

eflornithine

D11AX16

eprosartan and diuretics

C09DA02

ertapenem

J01DH03

etilevodopa and decarboxylase inhibitor

N04BA06

etoricoxib

M01AH05

everolimus

L04AA18

fasudil

C04AX32

frovatriptan

N02CC07

glutaral

D08AX09

gusperimus

L04AA19

helium

V03AN03

insulin aspart

A10AD05

lanthanum carbonate

V03AE03

levodopa, decarboxylase inhibitor and COMT inhibitor

N04BA03

levofloxacin

S01AX19

lofexidine

N07BC04

lovastatin, combinations

C10AA52

melagatran

B01AE04

melevodopa

N04BA04

melevodopa and decarboxylase inhibitor

N04BA05

methotrexate

L04AX03

moxonidine and diuretics

C02LC05

nitrogen

V03AN04

oxygen

V03AN01

pegvisomant

H01AX01

pimecrolimus

D11AX15

polygeline

B05AA10

rifampicin, pyrazinamide and isoniazid

J04AM05

rifampicin, pyrazinamide, ethambutol and isoniazid

J04AM06

rifapentin

J04AB05

telmisartan and diuretics

C09DA07

travoprost

S01EE04

ximelagatran

BO1AE05

ATC code changes:

Previous:

desirudin

B01AX02

New:

desirudin

B01AE01

Previous:

latanoprost

S01EX03

New:

latanoprost

S01EE01

Previous:

lepirudin

B01AX03

New:

lepirudin

B01AE02

Previous:

unoprostone

S01EX04

New:

unoprostone

S01EE02

ATC name changes:

Previous:

ethambutol, combinations

New:

ethambutol and isoniazid

J04AM03

Previous:

rifampicin, combinations

New:

rifampicin and isoniazid

J04AM02

Previous:

somatropin and analogues

New:

somatropin and somatropin agonists

H01AC

Previous:

streptomycin, combinations

New:

streptomycin and isoniazid

J04AM01

Previous:

thioacetazone, combinations

New:

thioacetazone and isoniazid

J04AM04

INN/common name

DDD

Unit

Adm.R

ATC code

anakinra

0.1

g

P

L04AA14

bosentan

0.25

g

O

C02KX01

dutasteride

0.5

mg

O

G04CB02

ertapenem

1

g

P

J01DH03*

etoricoxib

60

mg

O

M01AH05*

fentanyl

0.6

mg

SL

N02AB03f

ferric oxide dextran complex

0.1

g Fe₃⁺

P

B03AC06

fondaparinux

2.5

mg

P

B01AX05

frovatriptan

2.5

mg

O

N02CC07*

fulvestrant

8.3

mg

P

L02BA03

gatifloxacin

0.4

g

O,P

J01MA16

glatiramer acetate

20

mg

P

L03AX13

lofexidine

1.4

mg

O

N07BC04*

memantine

20

mg

O

N06DX01

miglustat

0.3

g

O

A16AX06

mometasone

0.4

mg

Inhal.powder

R03BA07

octreotide

0.7

mg

P

H01CB02

parecoxib

60

mg

P

M01AH04

peginterferon alfa-2a

26

mcg

P

L03AB11

risperidone

1.8

mg

P depot

N05AX08

tenecteplase

40

mg

P

B01AD11t

tenofovir disoproxil

0.245

g

O

J05AF07

tiotropium bromide

18

mcg

Inhal.powder

R03BB04

voriconazole

0.4

g

O,P

J02AC03

ziprasidone

40

mg

P

N05AE04

* Temporary ATC code

Change of DDDs:

Previous: levofloxacin

0.25

g

O,P

New: levofloxacin

0.5

g

O,P

J01MA12